시장 데이터 로딩 중...
2026년 8월 30일 일요일
LineVest LogoLineVest

LineVest

뉴스

미국 시장·금융 최신 뉴스

뉴스
Korea's New Bio 'Control Tower' Holds First CEO Sit-Down — The Real Test Is a Strategy Due This Month
뉴스

Korea's New Bio 'Control Tower' Holds First CEO Sit-Down — The Real Test Is a Strategy Due This Month

Korea's National Bioinnovation Committee held its first CEO meeting with pharma leaders on June 15, 2026. The real test comes with the Bio Innovation Strategy expected before end of June.

2026.06.15.0
Korea Investment Adds Auto-Investing Notes to KakaoBank App
뉴스

Korea Investment Adds Auto-Investing Notes to KakaoBank App

On June 15, two of Korea's largest brokerages made the same bet on the same day: that the cheapest way to reach retail savers is to rent the audience of Kakao's consumer apps rather than build their o

2026.06.15.1
LG Energy Solution Courts US AI Talent as Q1 Losses Persist
뉴스

LG Energy Solution Courts US AI Talent as Q1 Losses Persist

LG Energy Solution (373220.KS), the world's third-largest electric-vehicle battery maker, held its annual Battery Tech Conference (BTC) — a recruitment-linked event that invites graduate-level researc

2026.06.15.0
Korean Chips Jump 4-6% as U.S.-Iran Ceasefire Reopens Hormuz, Lifting KOSPI Past 8,500
뉴스

Korean Chips Jump 4-6% as U.S.-Iran Ceasefire Reopens Hormuz, Lifting KOSPI Past 8,500

South Korea's chipmakers led a broad risk-on surge on Monday after U.S. President Donald Trump declared that negotiations on a memorandum of understanding (MOU)

2026.06.15.0
Celltrion Adds Two Cancer Biosimilars in Vietnam
뉴스

Celltrion Adds Two Cancer Biosimilars in Vietnam

Celltrion is widening its footprint in Vietnam, a small but fast-growing Southeast Asian market — a move that tells investors more about strategy than about this quarter's revenue.

2026.06.15.1
Foreign Investors Trade $4.4B via Korea's Omnibus Accounts
뉴스

Foreign Investors Trade $4.4B via Korea's Omnibus Accounts

2026.06.14.0
Forest Partners Backs Battery 'Foundry' JR Energy Solution at ₩100 Billion in EV-Downturn Bet
뉴스

Forest Partners Backs Battery 'Foundry' JR Energy Solution at ₩100 Billion in EV-Downturn Bet

Forest Partners, a Seoul-based private equity firm, has invested more than ₩10 billion ($7.3 million) in JR Energy Solution, a battery contract manufacturer fou

2026.06.14.1
Samsung Electro-Mechanics, LG Innotek Set for Q2 Record as AI Substrate Squeeze Deepens
뉴스

Samsung Electro-Mechanics, LG Innotek Set for Q2 Record as AI Substrate Squeeze Deepens

SEMCO Q2 operating profit seen +79% to KRW380.7B; FC-BGA demand outstrips supply by over 50% with no new capacity before 2028. LG Innotek FY26 OP est. KRW1.1T.

2026.06.14.0
Overnight Lines Return as CJ Olive Young Opens Second U.S. Outpost Near Beverly Hills
뉴스

Overnight Lines Return as CJ Olive Young Opens Second U.S. Outpost Near Beverly Hills

CJ Olive Young opened its second U.S. store at Westfield Century City on June 13, 2026, as the USD 2 billion U.S. K-beauty market grew 37% in 2025 — the retailer now eyes a third California location a

2026.06.14.0
Hyundai Motor Group Advances to 11.8% U.S. Market Share Through April as Hybrids Absorb Tariff Shock
뉴스

Hyundai Motor Group Advances to 11.8% U.S. Market Share Through April as Hybrids Absorb Tariff Shock

Hyundai Motor Group claimed 11.8 percent of the U.S. auto market in the first four months of 2026, up one percentage point year-on-year, as hybrid sales surged 66 percent in January and a bilateral trade deal cut the tariff rate from 25 to 15 percent.

2026.06.14.2
Shinhan Folds Its Super-App Into SOL Bank as Korea's Lenders Reignite the Platform War
뉴스

Shinhan Folds Its Super-App Into SOL Bank as Korea's Lenders Reignite the Platform War

Shinhan Financial Group (055550.KS), Korea's second-largest financial holding company by assets, will relaunch its all-in-one "Super SOL" platform on June 17, but the new version quietly concedes that its first attempt missed. Rather than maintain a standalone super-app, Shinhan is embedding card, securities and insurance functions directly into SO

2026.06.14.0
K-Biotech's Animal-Free Pivot: Samsung Biologics and Peers Race to Meet New FDA and EU Drug Rules
뉴스

K-Biotech's Animal-Free Pivot: Samsung Biologics and Peers Race to Meet New FDA and EU Drug Rules

The EU and FDA are converging on a phaseout of animal testing in drug development, creating a new competitive arena where Samsung Biologics and a cohort of Korean biotech firms are building organoid and AI capabilities to stay ahead.

2026.06.14.2